.25 mg of semaglutide does work For patients with #obesity, semaglutide, a glucagon-like peptide-1 The UK's MRHA has approved

GLP-1 medications such as semaglutide and tirzepatide directly reduce hunger, slow stomach emptying, and help you feel full longer, which can significantly cut cravings

Constipation On the opposite end, constipation affected 24.2% of semaglutide 2.4 mg users versus 11.1% on placebo in the STEP trials

These medications are indicated for adults with a BMI 30 kg/m (obesity) or 27 kg/m (overweight) with at least one weight-related comorbidity

otherwise, the management of MDS will be mistakenly guided to focus on glycemic management

This dual benefit is particularly important because people with type 2 diabetes face a much higher risk of heart attack and stroke compared with the general population

This difference highlights how the drugs action on the digestive system can lead to discomfort